Cellply is a deep tech company with the ambition to develop analytical tools enabling fast end effective development of life-saving cancer cell therapies. Our solutions support biopharma companies and research institutes from discovery to R&D and quality control of advanced therapies. Our team features a unique combination of expertise in a diverse set of technology going from microfluidics to robotics, AI, biology and immunology.
TEAM
Operational team
Emiliano Spagnolo
Chief Executive Officer
Massimo Bocchi
Founder and Chief Strategy Officer
Andrea Faenza
Chief Technology Officer
Laura Rocchi
Head of Biology
Dario Biscarini
Project Manager
Chantal Pozzobon
Office Manager
Laura Rambelli
Laboratory and Warehouse Specialist
Rita Ruggiano
Project Leader Analytical SW
Luca Giulianelli
Head of Control SW
Nicola Pecorari
Senior Hardware Engineer
Alice Bettelli
Project Leader Analytical Methods
Silvia Bocchi
Project Leader Assay development
Laura Gruppioni
Junior Software Developer
Mark Atlas
Marketing and US Sales
INVESTORS
GRANTS & PROJECTS
ONCOSMART
Development of an In-Vitro Diagnostic platform for functional precision medicine to predict the outcome of hematological cancer patients
COVID-19 - Regione ER
Sviluppo di un test prognostico sulla base del profilo immunitario dei pazienti con Coronavirus Disease 19 (COVID-19) ospedalizzati
